Together, our results suggest that plasma NfL may not be sensitive to cross-sectional differences in cognition or measures of gray matter neurodegeneration, but may capture some cross-sectional differences in white matter pathology among early old age dementia-free men at ages 61–73 years. The gene discussed is NEFL; the disease is dementia.